Key points are not available for this paper at this time.
This study evaluated the risk factors for insulin therapy before 24 gestational weeks (early insulin therapy) in pregnant women with gestational diabetes diagnosed before 24 gestational weeks (E-GDM).
Kasuga et al. (Thu,) studied this question.